San Antonio-based Evestra recently announced in a press release that the company has entered into a strategic collaboration with Hungarian drug maker Gedeon Richter. The new agreement will put into place a partnership wherein Evestra will conduct R&D services on contraceptive products on Gedeon Richter’s behalf, and in exchange will license commercialization rights for certain territories outside the USA to Gedeon Richter. The press release indicates that there have been undisclosed upfront payments made on behalf of funding research and early development efforts, as well as clinical development, regulatory and sales performance milestones, and royalty payments on net sales.
Evestra has also announced that the company is planning to move its operations to the Texas Research Park in San Antonio, Texas. The crux of the move appears to be to accommodate new laboratory facilities, which the company says will enable a more efficient product pipeline, particularly in developing products that fulfill unmet medical needs for women’s health.
While Evestra is still considered an emerging biotech firm, the company has deep, proven expertise in the field of women’s health products. Established in October of 2007 as a spin-off company of the Organic Chemistry Department of Texas Biomedical Research Institute (formerly known as theSouthwest Foundation for Biomedical Research (SFBR)), located in San Antonio, Texas, Evestra, Inc. has been in full operation since 2008 on the Texas Biomed campus, with their facilities including a GMP manufacturing site. Currently, the company is in the research phase of product development for several products that seek to meet critical unmet needs in women’s health, such as endometriosis and hormonal-dependent breast cancer. Evestra maintains a contractual relationship with the National Institute of Child Health Development and a collaboration with the NIH in synthesizing, for subsequent biological testing, a variety of steroid compounds targeting fertility control and HRT. The collaboration includes leading endocrinologists from the University of Texas Health Science system.